腹腔镜射频消融与子宫肌瘤剔除术的治疗失败比较
基于多中心前瞻性ULTRA研究,比较腹腔镜射频消融(RFA)与腹腔镜子宫肌瘤剔除术的症状性子宫肌瘤治疗失败情况。RFA组(n=231)2年内手术失败率15.2%,复合失败率46.4%;肌瘤剔除组(n=110)分别为3.8%和25.5%,调整后OR分别为4.17和3.18。RFA与更高的手术和复合失败风险相关,黏膜下和侧壁肌瘤与RFA失败相关。
要点
- RFA组2年手术失败率15.2%,显著高于肌瘤剔除组的3.8%(aOR 4.17)。
- RFA组复合失败率46.4%,肌瘤剔除组25.5%(aOR 3.18)。
- 黏膜下和侧壁肌瘤与RFA失败风险升高相关。
核心结论
- 腹腔镜RFA治疗子宫肌瘤在2年时的手术和复合失败风险高于腹腔镜肌瘤剔除术,即使调整基线差异后仍显著。
研究设计与样本
- 多中心前瞻性ULTRA研究的事后分析,比较腹腔镜RFA(n=231)与腹腔镜肌瘤剔除术(n=110)的症状性子宫肌瘤患者。
主要发现
- RFA组手术失败率15.2%,肌瘤剔除组3.8%(aOR 4.17;95% CI,1.39-12.50)。
- RFA组复合失败率46.4%,肌瘤剔除组25.5%(aOR 3.18;95% CI,1.80-5.60)。
- RFA组中黏膜下肌瘤与失败相关(OR 2.76;95% CI,1.21-6.28),肌瘤剔除组呈非显著趋势(OR 3.00;95% CI,0.99-9.05)。
- 侧壁肌瘤与RFA失败风险升高相关(OR 2.49;95% CI,1.32-4.69),肌瘤剔除组无任何肌瘤位置与失败相关。
临床怎么用
- 咨询症状性子宫肌瘤患者时,应告知RFA相比肌瘤剔除术有更高的2年手术和复合失败风险。
- 对于黏膜下或侧壁肌瘤患者,选择RFA需更谨慎评估失败风险。
局限性
- 两组基线特征存在显著差异(RFA组年龄更大、BMI、孕产次更高),虽经多变量调整仍可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare treatment failure and factors associated with failure between laparoscopic radiofrequency ablation (RFA) of leiomyomata and laparoscopic myomectomy. METHODS: We analyzed data from the multicenter prospective ULTRA (Uterine Leiomyoma Treatment with Radiofrequency Ablation) study, which investigated laparoscopic RFA and laparoscopic myomectomy for symptomatic uterine leiomyomata. Our primary outcome was receipt of any subsequent procedure (surgical failure) for leiomyomata within 2 years of the procedure. Our secondary outcome was composite failure (surgical failure or any self-reported failure, eg, continued leiomyomata symptoms affecting quality of life) within 2 years of the procedure. Odds ratios (ORs) were generated from multivariable logit models adjusting for a priori selected covariates. RESULTS: We identified significant baseline differences between our groups. The RFA group (n=231) was older and had higher body mass index (BMI), gravidity, and parity than the myomectomy group (n=110). In the RFA group, 15.2% experienced surgical failure compared with 3.8% in the myomectomy group (adjusted odds ratio [aOR] 4.17; 95% CI, 1.39-12.50), and 46.4% experienced composite failure in the RFA group compared with 25.5% in the myomectomy group (aOR 3.18; 95% CI, 1.80-5.60). Submucosal leiomyomata were associated with failure in the RFA group (OR 2.76; 95% CI, 1.21-6.28); there was a nonsignificant trend toward failure in the myomectomy group (OR 3.00; 95% CI, 0.99-9.05). Lateral leiomyomata were associated with higher odds of RFA failure (OR 2.49; 95% CI, 1.32-4.69), but no leiomyoma position was associated with myomectomy failure. CONCLUSION: Laparoscopic RFA of leiomyomata is associated with higher odds of surgical and composite failure compared with laparoscopic myomectomy at 2 years, even after adjusting for baseline differences between groups. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT02100904.
引用
- Brito KS, Schembri M, Parvataneni R, et al. Treatment Failure After Laparoscopic Radiofrequency Ablation Compared With Myomectomy. Obstet Gynecol. 2026. PMID: 42868327. doi:10.1097/AOG.0000000000006444
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。